No results found for “”
No results found for filter “”
-
Statements & press releases 20.11.23
EU pharmaceutical legislation: tackling the AMR innovation challenge for a healthier future
Confronting this complex challenge requires a comprehensive approach, encompassing enhanced surveillance, prudent use, preventive measures, and the development...
Read Article -
Blog articles 20.11.23
AMR case study: cystic fibrosis patients live in fear of infection
Patient advocates in Poland are fighting to improve access to antibiotics and to enhance infection control infrastructure in hospitals
Read Article -
Blog articles 20.11.23
AMR in Central & Eastern Europe: What do patients think?
Antimicrobial resistance (AMR) is highest in central and eastern Europe ‒ we asked patient advocates how they are impacted and what can be done to solve...
Read Article -
Blog articles 07.11.23
Improving men's health standards in Europe: a vital need for action (Guest blog)
As #Movember kicks off, we turn to two experts from the Let’s Talk Prostate Cancer (LTPC) Expert Group to shed light on the state of men's health in Europe....
Read Article -
Statements & press releases 06.11.23
Germany, Belgium and France among those hit hardest as Commission’s Pharma-legislation proposals risk...
New research shows Europe could lose 8% of total pharmaceutical innovation in the next 15 years
Read Article -
EFPIA News 27.10.23
Stefan Oelrich's interview at the POLITICO Health Care Summit
Watch the recording.
Read Article -
Statements & press releases 26.10.23
EFPIA statement on the European Commission's Communication on addressing medicine shortages in the EU...
Solutions to address shortages need to be fit for purpose targeting the specific root causes
Read Article -
Blog articles 26.10.23
What is innovation in medicines?
How we define and incentivise medical innovation will shape future waves of medical progress. We need a system where the early-stage research and incremental...
Read Article -
Statements & press releases 20.10.23
Product Liability Directive: European industry calls for a major rethink
The new proposal may open the door to a litigation culture in Europe.
Read Article -
EFPIA News 15.10.23
EFPIA Japan Day 2023
With a delegation from EFPIA in Brussels, EFPIA Japan recently held “EFPIA Day” in Tokyo
Read Article -
Statements & press releases 11.10.23
New report urges “rethink of European cancer services” to meet future demand for care
With five new cancer patients diagnosed every minute in Europe, experts estimate that the region will see a shortage of 4.1 million healthcare workers...
Read Article -
Blog articles 05.10.23
Supporting Europe’s Informal Carers: a call to action for Pharma companies (Guest blog)
Informal carers across the EU play an invaluable role in the healthcare ecosystem. They provide essential physical, emotional and logistical support to...
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 27.10.23
Stefan Oelrich's interview at the POLITICO Health Care Summit
Watch the recording.
Read Article -
EFPIA News 15.10.23
EFPIA Japan Day 2023
With a delegation from EFPIA in Brussels, EFPIA Japan recently held “EFPIA Day” in Tokyo
Read Article -
EFPIA News 13.07.23
Joint Position Paper on the Hospital Exemption Scheme for ATMPs
Our organisations are committed to engage with policymakers and interested stakeholders for an inclusive and solutions-driven approach on the HE in the...
Read Article -
EFPIA News 13.07.23
Access to oncology combination therapies in Europe: Today's challenges and solutions
Despite the significant value combination therapies bring to cancer care, there are several challenges to their access in Europe. Without action, some...
Read Article -
EFPIA News 12.06.23
IHI Calls 4 and 5: Publication of draft topics and opening of registration to call days
IHI Call Days: Calls 4 & 5
Read Article -
EFPIA News 27.04.23
IHI seeks patients and caregivers to contribute to its activities
IHI is calling on patients and informal caregivers to apply to be part of a new IHI Patient Pool which will strengthen IHI’s ties with the patient community,...
Read Article -
EFPIA News 15.12.22
EFPIA survey among member companies on compliance with the EFPIA-PHRMA principles for responsible clinical...
EFPIA members continue to be committed to responsible clinical trial data sharing, for the benefit of patients and researchers
Read Article -
EFPIA News 13.12.22
IHI launches new funding round
The Innovative Health Initiative (IHI) has launched its third call for proposals, featuring topics covering rare diseases and mental health, and addressing...
Read Article -
EFPIA News 07.11.22
Europe’s share of global medicines R&D shrinks by a quarter in 20 years – as sector’s declining trends...
EFPIA is warning that the options being discussed by policy makers in the context of the EU Pharma Strategy fall well short of addressing concerns and...
Read Article -
EFPIA News 05.10.22
Pharmaceutical industry response to the war in Ukraine
Supporting people affected by the war
Read Article -
EFPIA News 16.06.22
European Multi-Stakeholder Sounding Board Meeting on “Innovation – The key to sustainable cancer care”...
Join the sounding board to discuss how high-quality care pathways and innovation can alleviate the pressure, improve sustainable patient access to high...
Read Article -
EFPIA News 24.05.22
RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!
Now is the time to rethink Alzheimer’s disease to improve Alzheimer’s disease care pathway and the lives of people living with it.
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 20.11.23
EU pharmaceutical legislation: tackling the AMR innovation challenge for a healthier future
Confronting this complex challenge requires a comprehensive approach, encompassing enhanced surveillance, prudent use, preventive measures, and the development...
Read Article -
Statements & press releases 06.11.23
Germany, Belgium and France among those hit hardest as Commission’s Pharma-legislation proposals risk...
New research shows Europe could lose 8% of total pharmaceutical innovation in the next 15 years
Read Article -
Statements & press releases 26.10.23
EFPIA statement on the European Commission's Communication on addressing medicine shortages in the EU...
Solutions to address shortages need to be fit for purpose targeting the specific root causes
Read Article -
Statements & press releases 20.10.23
Product Liability Directive: European industry calls for a major rethink
The new proposal may open the door to a litigation culture in Europe.
Read Article -
Statements & press releases 11.10.23
New report urges “rethink of European cancer services” to meet future demand for care
With five new cancer patients diagnosed every minute in Europe, experts estimate that the region will see a shortage of 4.1 million healthcare workers...
Read Article -
Statements & press releases 03.10.23
European Commission’s draft Pharmaceutical Legislation proposals will harm patient access to medicines...
We have to make sure that the legislation works for patients and healthcare systems, and we must also stop and reverse the downward trends in Europe’s...
Read Article -
Statements & press releases 28.09.23
Evidence shows more than 600 essential medicines at risk, and manufacturing in Europe will ‘grind to...
A proposed restriction on the use of fluorinated substances across the EEA could see the widespread shut down of medicines manufacturing, according to...
Read Article -
Statements & press releases 22.09.23
Orphan medicines: How the draft pharmaceutical legislation proposals would impact rare disease patients?...
As currently drafted, the European Commission proposals contained in the revised legislation would discourage the development of 45 rare disease treatments...
Read Article -
Statements & press releases 13.09.23
SOTEU 2023: Reconciling policy and practice
Our hope now is that we can work with all parties to make the legislation enhance rather than hinder European competitiveness
Read Article -
Statements & press releases 12.09.23
Improving the understanding, acceptance and use of oncology–relevant endpoints in HTA body / payer decision-making...
How can we ensure that oncology-relevant endpoints reflect the value of innovation for patients, clinicians, payers and society?
Read Article -
Statements & press releases 12.09.23
EFPIA working with Ukraine on EU accession and medicines and vaccines regulatory alignment and patient...
Representatives from the European Federation of Pharmaceutical Industries and Associations (EFPIA) today met in Brussels with a high-level Ukrainian government...
Read Article -
Statements & press releases 06.09.23
EFPIA attends meeting to discuss opt-out requirements in EHDS
An opt-out or opt-in mechanism with regard to the secondary use of electronic health data may lead to health data disparities.
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 20.11.23
AMR case study: cystic fibrosis patients live in fear of infection
Patient advocates in Poland are fighting to improve access to antibiotics and to enhance infection control infrastructure in hospitals
Read Article -
Blog articles 20.11.23
AMR in Central & Eastern Europe: What do patients think?
Antimicrobial resistance (AMR) is highest in central and eastern Europe ‒ we asked patient advocates how they are impacted and what can be done to solve...
Read Article -
Blog articles 07.11.23
Improving men's health standards in Europe: a vital need for action (Guest blog)
As #Movember kicks off, we turn to two experts from the Let’s Talk Prostate Cancer (LTPC) Expert Group to shed light on the state of men's health in Europe....
Read Article -
Blog articles 26.10.23
What is innovation in medicines?
How we define and incentivise medical innovation will shape future waves of medical progress. We need a system where the early-stage research and incremental...
Read Article -
Blog articles 05.10.23
Supporting Europe’s Informal Carers: a call to action for Pharma companies (Guest blog)
Informal carers across the EU play an invaluable role in the healthcare ecosystem. They provide essential physical, emotional and logistical support to...
Read Article -
Blog articles 04.10.23
Precision Medicine and Population Health: a contradiction or a way forward? (Guest blog)
By focusing on individual information and genomics and channeling the right approach to the right patient at the right time, we can reach benefits at population...
Read Article -
Blog articles 26.09.23
Affordability of medicines is a two-sided coin (Guest blog)
Pharmaceutical expenditure has remained stable at around 15% of healthcare spending in most European countries over the past 20 years. Beyond pharmaceutical...
Read Article -
Blog articles 21.09.23
Rethinking Alzheimer's Disease: A Call to Action for Early Detection and Diagnosis
Charting a course to improve early detection and timely diagnosis of Alzheimer’s in Europe
Read Article -
Blog articles 05.09.23
How the pharmaceutical industry is contributing to mitigate climate change
New industry survey highlights commitments and ambitions of 23 global pharmaceutical companies
Read Article -
Blog articles 01.08.23
Lung cancer: meeting patients’ needs through innovation
An inclusive definition of unmet medical need is vital to driving better outcomes for patients
Read Article -
Blog articles 14.07.23
Are European policy makers losing interest in health?
What the European Semester 2023 tells us of the future of European health policy
Read Article -
Blog articles 12.07.23
Unlocking the potential of precision oncology (Guest Blog)
The potential of precision oncology is there. To unleash it, we need to move forward together, working on ways to advance regulatory science, to screen...
Read Article